Zebron ZB-5MSPLUS™

Importance of the topic

Zebron ZB-5MSPLUS addresses the need for highly inert gas chromatography columns to improve detection of active and labile analytes. Poor inertness in traditional phases leads to analyte adsorption, degradation, and tailing that compromise sensitivity and reproducibility. This next-generation 5% phenyl-arylene phase supports broad applications in food safety, environmental screening, pharmaceutical testing, and forensic analysis by maximizing response and peak shape without changing method parameters.

Objective and overview of the study

This whitepaper introduces the Zebron ZB-5MSPLUS GC column family, highlighting its improved inertness and robustness while maintaining the selectivity of conventional 5ms phases. Key goals include benchmarking performance against market-leading alternatives, presenting quality control criteria, and demonstrating application versatility through case studies in cannabinoid, melamine, drug of abuse, and ethanolamine analyses.

Methodology and Instrumentation

Instrumental parameters were optimized to directly compare ZB-5MSPLUS with competing 5ms columns from Agilent, Restek, and Supelco under standardized conditions (30 m × 0.25 mm × 0.25 µm, helium carrier, FID or MSD detection). A rigorous fused silica deactivation protocol was applied during manufacturing to minimize active sites. Quality control tests include:

• Analyte screening: pyridine, alcohols, diols, chlorinated aromatics and hydrocarbons to assess inertness, polarity and retention stability;
• Efficiency measurements: average >4,000 plates/m, surpassing the 3,700 plates/m industry baseline;
• Bleed and stability evaluation: low bleed for enhanced sensitivity over repeated injections;

Case study protocols for GC/MS methods included extraction and derivatization steps for cannabinoids in brownies, melamine in pet food, drug panels in methanol, and ethanolamines, illustrating real-world workflows.

Main results and discussion

ZB-5MSPLUS consistently delivered sharper, symmetric peaks for active analytes such as 1,2-butanediol (peak skew 0.786 vs. 0.580–0.535), pyridine, chlorophenols, and diols. Comparative data show retention alignment and selectivity equivalent to standard 5ms phases. In the QC screen, inertness metrics exceeded controls, and column bleed remained minimal at high temperatures. Case studies demonstrated:

• Cannabinoids achieved clear separation and robust detection at 1 µg/g levels in chocolate matrices;
• Melamine derivatives in dog food showed baseline resolution at 100 µg/g after derivatization;
• A 23-compound drugs of abuse panel resolved within a single run without ghost peaks;
• Ethanolamine isomers separated with sharp peaks free of tailing.

Benefits and practical applications

The simplified transition to ZB-5MSPLUS allows laboratories to upgrade inertness without revalidating methods. Improved analyte response enhances sensitivity for trace-level targets across food analysis, environmental screening, toxicology, and quality control. Low bleed and high efficiency extend column lifetime and reduce baseline noise, facilitating method robustness and reproducibility.

Future trends and potential applications

Advances in deactivation chemistry will continue to push inertness in GC stationary phases. We anticipate broader phase portfolios tailored for specific compound classes, integration with automated sample preparation and high-throughput screening, and coupling with emerging detectors. The emphasis on green chemistry and rapid screening holds potential for next-generation columns in clinical metabolomics and bio-analytical fields.

Conclusion

Zebron ZB-5MSPLUS represents a significant evolution in GC column inertness, maintaining familiar selectivity while delivering superior peak shape, sensitivity, and reliability. Its compatibility with existing methods and proven performance across diverse applications make it a compelling choice for analytical laboratories seeking to maximize detection power and method efficiency.

References

None